Search Results for: NYC LOCATIONS

OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19)

OPKO Health’s BioReference Laboratories and NYC Health + Hospitals Enter into Laboratory Collaboration to Provide Testing for Coronavirus Disease 2019 (COVID-19) BioReference Laboratories commits to testing 5,000 New Yorkers each day ELMWOOD PARK, N.J., March 17, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the New York City […]

New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy

Locations now open in NYC with more to follow across the State  NEW YORK CITY, February 22, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19 rapid testing around New York. This program is designed to provide New Yorkers, and those visiting, with inexpensive and rapid COVID-19 testing.  NY Forward is a collaboration with The Empire State Development Corporation, The Real Estate Board of New York (REBNY), the […]

OPKO Health’s BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools

Through New York City, BioReference will be testing students, teachers and staff in nearly 1,000 NYC public schools ELMWOOD PARK, N.J., October 9, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school […]

OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]

OPKO Health’s BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees

Based on internal data, 29% of nursing home employees tested positive for antibodies Since the beginning of the COVID-19 pandemic, BioReference has performed 222,000 COVID-19 PCR and 3,500 antibody tests in over 350 facilities ELMWOOD PARK, N.J., July 1, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR […]

OPKO Health’s BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents

In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]

OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)

ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]

OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)

BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]

OPKO Health’s BioReference Laboratories and City of Detroit Provide Testing for Coronavirus Disease 2019 (COVID-19)

BioReference will offer COVID-19 testing for public drive-through facilities for Detroit residents ELMWOOD PARK, N.J., March 23, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Detroit to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations for Detroit residents by appointment. “The impact that expanded testing will […]